The initial public offering (IPO) of GoodRx (NASDAQ:GDRX) this week drew significant investor interest. Shares jumped almost 50% in the first day of trading, from an already lofty IPO price of $33.
Beyond its strong revenue growth and earnings, the company's mission moves healthcare in a direction that both political parties can agree on. The rare bipartisan support for reducing prescription drug prices in today's polarized political climate means that GoodRx is in a position to potentially shake up the pharmaceutical industry.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,